Embedded Files
We AI-mpower
Unlock the Future of Clinical Studies with deepeye® Research
Unlock the Future of Clinical Studies with deepeye® Research
At deepeye®, we're redefining the landscape of retinal therapy research, merging advanced artificial intelligence with deep clinical expertise. Our approach is rooted in the successful methodologies of Europe's esteemed reading and study centers, known for their significant contributions to major phase III and IV trials of anti-VEGF agents.
deepeye® Research: For Leading Researchers
deepeye® Research: For Leading Researchers
Our flexible AI platform elevates the capabilities of retinal therapy study teams, serving pharmaceutical companies, medical device manufacturers and payors with unparalleled efficiency and insight.
Enhancing Your Research Capabilities
Enhancing Your Research Capabilities
AI-empowered Phase IV: Leverage our real-world therapy-focused AI to deepen your data understanding in non-interventional studies, like most leading pharma companies do already.
Unlocking Insights from Phase II-III Data: Engage in retrospective analysis to uncover new insights of your existing OCT and clinical data. With our network of leading research partners, we can assure top-notch, unbiased publication of results you can use for therapy differentiation.
Support in Leveraging your Data
Support in Leveraging your Data
Rich Data Inputs and Outputs: Handle large, diverse OCT and clinical datasets with ease, converting them into anonymized, standardized data paired with insightful AI reports.
Beyond Biomarkers: Our tool goes one step further than conventional biomarker quantification tools and delivers actionable insights on treatment patterns. We provide a comprehensive analysis of retinal therapy.
We Help you Find the Right AI for your Research
We Help you Find the Right AI for your Research
Our tool is fully focused on retinal therapy. We work with leading scientific research partners to make sure we deliver new insights to you.
If you are only looking at quantifying retinal fluids, we are happy to recommend you one of the great tools already out there!
We also focus on approval and commercialization stage of retinal therapy.
If you are only looking at drug discovery and phase I-IIa studies, we can know AI tools from other companies that might be a better for you.
In any case, we are here to help!
A Partnership for Innovation
A Partnership for Innovation
deepeye® Research: More than a tool, a commitment to precision medicine.
Advance Clinical Studies: Critical insights for treatment strategies in phases II-IV.
Comprehensive Analysis: In-depth data analysis and insightful publications.
Improved Therapy Adherence and Outcomes: A shared vision in retinal therapy research.
Collaborative Approach: Forge new paths with a dedicated partner.
Get in touch
Page updated
Report abuse